EID: Bridging the Gap Between Humans and Wildlife

Sometime in the 1980s, the emerging infectious disease (EID) movement began. The "emerging" label had been used earlier, but a series of high-profile disease outbreaks in the 1980s, combined with perceived funding gaps, began to galvanize the field. A book by Richard Krause of the National Institutes of Health1 formed part of the initial thrust. Published in the same year as the recognition of AIDS, it commented on the alarming phenomenon of antibiotic-resistant microbes. Further threats surfac

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share



Sometime in the 1980s, the emerging infectious disease (EID) movement began. The "emerging" label had been used earlier, but a series of high-profile disease outbreaks in the 1980s, combined with perceived funding gaps, began to galvanize the field. A book by Richard Krause of the National Institutes of Health1 formed part of the initial thrust. Published in the same year as the recognition of AIDS, it commented on the alarming phenomenon of antibiotic-resistant microbes. Further threats surfaced: Legionnaire's disease, toxic shock syndrome, multiple-drug resistance in a host of important pathogens, Lyme disease, and others.

The year 1992 saw the publication of an Institute of Medicine treatise on emerging infections,2 and a special section in Science talked about a "post-antimicrobial era," tuberculosis as a "reemergent killer," and the "crisis in antibiotic resistance." This was rapidly followed by Emerging Viruses3 by Stephen S. Morse of Rockefeller University, and another Science section included ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Peter Daszak

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo